Abstract:Diet-metabolite associations for foods high in monounsaturated fatty acids (MUFAs) differ between those with normo- vs. with dys- glycemia. As metabolites represent the physiological effects of food after it has been digested, processed, and absorbed, this suggests that dysglycemia alters how foods are metabolized and thus their potential health impacts. Our goal was to examine whether metabolites associated with adherence to a MSD, a diet high in MUFA, differed by glycemia status (normoglycemia vs. IFG [125<FG≥110 mg/dL]). We leveraged the longitudinal data on diet and plasma metabolites (N=2,816) in MESA-TOPMed, collected at two exams ~10y apart (baseline (BL): 2000-2002, and follow-up (FU): 2010-2011), on ~3,700 multi-ethnic US adults, ages 44-84y at baseline. Between exams, the proportion of the population with IFG increased from 25% to 40% (P<1.0*10 -16 ), providing a natural experiment to examine how MSD-metabolite associations change alongside population-level glycemia changes. We interpreted linear models which specified metabolites values as the outcome, and MSD score as the predictor, and adjusted for demographic (age, gender, race/ethnicity, income level, highest education level) and health behavior (physical activity, energy intake, smoking status, body mass index [BMI]) information, with longitudinal models also including time as a fixed effect (days since BL). Longitudinal random-intercept multi-level models identified 789 compounds associated with MSD at metabolome wide levels of significance (P<1.8*10 -5 ). Significant diet-by-time interactions (P<.05) indicated that the 241 metabolites showed associated with MSD that were time-specific, changing as population dysglycemia increased (alongside changes in other characteristics), and we observed different effect sizes for MSD-metabolite associations in those with IFG vs those with normoglycemia (t = 3.4, df = 145, P = 9.0*10 -4 ). 548 metabolites showed associations with an MSD that were time-invariant, and when analyses were stratified by glycemia status, more of these more ‘universally associated’ metabolites were significantly associated with an MSD in those with IFG and normoglycemia, vs. in just one dysglycemia group (45% vs. 15%; X 2 =117, df=2, P<2.0*10 -16 ). Our longitudinal analyses demonstrated that population-level metabolite associations with an MSD change as the population dysglycemia changes. Of course, other characteristics changed as well, and only some of these (e.g., BMI and age) were controlled for in our analyses. However, our cross-sectional analyses provided additional evidence that MSD-metabolite associations differ between those with normoglycemia vs. IFG. We are now seeking replication in other TOPMed cohorts, to support that notion that tailoring dietary advice to T2D prevention vs. management would be an important direction for future precision nutrition efforts.

Multidisciplinary approach combining food metabolomics and epidemiology identifies meglutol as an important bioactive metabolite in tempe, an Indonesian fermented food

Metabolomics insights of conventional and organic tempe during in vitro digestion and their antioxidant properties and cytotoxicity in HCT-116 cells

Identification of Dietary Supplements Associated with Blood Metabolites in the Hispanic Community Health Study/Study of Latinos Cohort Study

Abstract MP23: Circulating Gut Microbiota-Related Metabolites and Risk of Coronary Heart Disease: A Prospective, Multiethnic, Metabolomic Study

Metabolite Changes in Indonesian Tempe Production from Raw Soybeans to Over-Fermented Tempe

Metabolomics-Based Study of the Effect of Raw Materials to the End Product of Tempe—An Indonesian Fermented Soybean

Mapping the Metabolic Profiles of Long-Term Vegetable, Fruit, and Fruit Juice Consumption

Developing Biomarkers of Rice Bran and Navy Bean Intake via Integrated Metabolomics from Infants, Children and Adults for Association with Gut Health Properties

Abstract 022: Plasma Metabolome Related To Plant-based Diets And The Association With Type 2 Diabetes: A Prospective Cohort Study

Genome-wide association and Mendelian randomization analysis prioritizes bioactive metabolites with putative causal effects on common diseases

Abstract P498: Different Metabolomic Associations With Mediterranean Style Diet (MSD) Scores Between Individuals With Normoglycemia vs. Impaired Fasting Glucose (IFG) in the Multi-Ethnic Study of Atherosclerosis Transomic Precision Medicine Initiative (MESA-TOPMed) Data

Plasma metabolomic profiling of dietary patterns associated with glucose metabolism status: The Maastricht Study

Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality

Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes

Effects of Different Combinations of Phytochemical-Rich Fruits and Vegetables on Chronic Disease Risk Markers and Gene Expression Changes: Insights from the MiBLEND Study, a Randomized Trial

Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program

Bioavailable Microbial Metabolites of Flavanols Demonstrate Highly Individualized Bioactivity on In Vitro β-Cell Functions Critical for Metabolic Health

Metabolomics and molecular docking-directed anti-obesity study of the ethanol extract from Gynostemma pentaphyllum (Thunb.) Makino

Current status on genome–metabolome-wide associations: an opportunity in nutrition research

Exhaustive Search of Dietary Intake Biomarkers as Objective Tools for Personalized Nutrimetabolomics and Precision Nutrition Implementation

Dietary Polyphenols to Combat the Metabolic Diseases Via Altering Gut Microbiota